Heart failure with mildly reduced ejection fraction: emerging frontiers in clinical characteristics, prognosis, and treatment [PDF]
Reviews in Cardiovascular Medicine, 2022 Heart failure (HF) is a complex clinical syndrome resulting from the impairment of ventricular filling or ejection of blood or both, leading to considerable morbidity and mortality. Based on left ventricular ejection fraction (LVEF), the 2016 European
Zhi Shang, Xinyu Wang, Wei Gao
doaj +1 more source
Heart failure with mid-range ejection fraction. Where are we today? [PDF]
Българска кардиология, 2021 Bulgarian Society of Cardiology adhere to the European Guidelines on Heart Failure (HF). The fi nalized studies and many debates and analyses after 2016 are prerequisite to creation of a new guideline for diagnosis and management on these patients.
Tzvetana Katova
doaj +3 more sources
What is Heart Failure with Mid-range Ejection Fraction? A New Subgroup of Patients with Heart Failure. [PDF]
Card Fail Rev, 2018 Nadar SK, Tariq O.
europepmc +3 more sources
Similarities and Differences Between HFmrEF and HFpEF
Frontiers in Cardiovascular Medicine, 2021 The new guidelines classify heart failure (HF) into three subgroups based on the ejection fraction (EF): HF with reduced EF (HFrEF), HF with mid-range EF (HFmrEF), and HF with preserved EF (HFpEF).
Peixin Li +15 more
doaj +1 more source
Comorbidities in heart failure with mid-range ejection fraction [PDF]
European Journal of Internal Medicine, 2017 Dear Sir, The recent Guidelines of heart failure (HF) of the European Society of Cardiology (ESC) propose an emerging classification of HF according to left ventricular ejection fraction (LVEF). Namely, patients with LVEF between 40 and 50% are classified in an intermediate group termed HF with mid-range ejection fraction (HFmrEF). Although the authors
Perez-Calvo, Juan Ignacio +3 more
openaire +3 more sources
Sirt1 Activity in PBMCs as a Biomarker of Different Heart Failure Phenotypes
Biomolecules, 2020 Heart Failure (HF) is a syndrome, which implies the existence of different phenotypes. The new categorization includes patients with preserved ejection fraction (HFpEF), mid-range EF (HFmrEF), and reduced EF (HFrEF) but the molecular mechanisms involved ...
Valeria Conti +14 more
doaj +1 more source
ESC Heart Failure, 2022 Aims In the heart failure (HF) with preserved ejection fraction (HFpEF) PARAGON‐HF trial, sacubitril/valsartan vs. valsartan improved mortality/morbidity in patients with left ventricular ejection fraction (LVEF) below median (57%).
Lars H. Lund +9 more
doaj +1 more source
Characteristics and long-term prognosis of patients with heart failure and mid-range ejection fraction compared with reduced and preserved ejection fraction: a systematic review and meta-analysis. [PDF]
ESC Heart Fail, 2018 Lauritsen J, Gustafsson F, Abdulla J.
europepmc +2 more sources
ESC Heart Failure, 2021 Aims The role of diastolic dysfunction (DD) in prognostic evaluation in heart failure (HF) patients with impaired systolic function remains unclear.
Dan Liu +9 more
doaj +1 more source
Does heart failure with mid-range ejection fraction resemble heart failure with preserved ejection fraction? [PDF]
The International Journal of Cardiovascular Imaging, 2020 [No abstract available]
Özlek, Bülent, Özlek, Eda
openaire +2 more sources